ATA352783A - Verfahren zur herstellung neuer dichlorierter derivate aus der reihe der 16alpha -methylpregnane - Google Patents
Verfahren zur herstellung neuer dichlorierter derivate aus der reihe der 16alpha -methylpregnaneInfo
- Publication number
- ATA352783A ATA352783A AT0352783A AT352783A ATA352783A AT A352783 A ATA352783 A AT A352783A AT 0352783 A AT0352783 A AT 0352783A AT 352783 A AT352783 A AT 352783A AT A352783 A ATA352783 A AT A352783A
- Authority
- AT
- Austria
- Prior art keywords
- dichlorated
- methylpregnane
- 16alpha
- derivatives
- range
- Prior art date
Links
- TXTGPWLZHZYCQV-YFOXLAJYSA-N (8s,9s,10s,13r,14s,17s)-10,13-dimethyl-17-propyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](CCC)[C@@]1(C)CC2 TXTGPWLZHZYCQV-YFOXLAJYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/13—Monohydroxylic alcohols containing saturated rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C68/00—Preparation of esters of carbonic or haloformic acids
- C07C68/02—Preparation of esters of carbonic or haloformic acids from phosgene or haloformates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
- C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8216668A FR2533928A1 (fr) | 1982-10-05 | 1982-10-05 | Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA352783A true ATA352783A (de) | 1987-11-15 |
| AT385996B AT385996B (de) | 1988-06-10 |
Family
ID=9277977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0352783A AT385996B (de) | 1982-10-05 | 1983-10-05 | Verfahren zur herstellung neuer dichlorierter derivate aus der reihe der 16alpha -methylpregnane |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4515787A (de) |
| JP (1) | JPS59116300A (de) |
| AT (1) | AT385996B (de) |
| AU (1) | AU563739B2 (de) |
| BE (1) | BE897906A (de) |
| CA (1) | CA1203234A (de) |
| CH (1) | CH659251A5 (de) |
| DE (1) | DE3336292A1 (de) |
| DK (1) | DK164062C (de) |
| ES (1) | ES526212A0 (de) |
| FI (1) | FI77668C (de) |
| FR (1) | FR2533928A1 (de) |
| GB (1) | GB2127827B (de) |
| HU (1) | HU190506B (de) |
| IE (1) | IE56022B1 (de) |
| IT (1) | IT1197713B (de) |
| MA (1) | MA19909A1 (de) |
| NL (1) | NL8303409A (de) |
| NO (1) | NO157864C (de) |
| OA (1) | OA07558A (de) |
| SE (1) | SE447388B (de) |
| ZA (1) | ZA836538B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2561919B1 (fr) * | 1984-04-03 | 1986-12-19 | Roussel Uclaf | Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon |
| GB8512738D0 (en) * | 1984-09-04 | 1985-06-26 | Gen Electric | Silylation method |
| EP1079859B1 (de) | 1998-05-22 | 2010-07-14 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunktionelle moleküle sowie darauf basierende therapien. |
| US7247607B2 (en) * | 2001-11-08 | 2007-07-24 | Green & Clean, Inc. | Active soluble cleaning composite of natural state using soybean fatty acids and the making method thereof |
| SI1889198T1 (sl) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Farma-informacijski sistem |
| JP2009508494A (ja) | 2005-09-16 | 2009-03-05 | ラプトール ファーマシューティカル インコーポレイテッド | Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用 |
| DK2398500T3 (da) | 2009-02-20 | 2019-05-13 | 2 Bbb Medicines B V | Glutathion-baseret lægemiddelafgivelsessystem |
| ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2342738A1 (fr) * | 1976-03-02 | 1977-09-30 | Roussel Uclaf | Nouveaux derives halogenes de la serie du 16a-methyl pregnane |
| FR2381065A2 (fr) * | 1977-02-22 | 1978-09-15 | Roussel Uclaf | Nouveaux derives halogenes de la serie du 16 a-methyl pregnane |
| FR2462443A1 (fr) * | 1979-07-26 | 1981-02-13 | Roussel Uclaf | Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament |
-
1982
- 1982-10-05 FR FR8216668A patent/FR2533928A1/fr active Granted
-
1983
- 1983-07-20 SE SE8304062A patent/SE447388B/sv not_active IP Right Cessation
- 1983-07-27 NO NO832738A patent/NO157864C/no unknown
- 1983-09-03 ZA ZA836538A patent/ZA836538B/xx unknown
- 1983-09-15 US US06/532,739 patent/US4515787A/en not_active Expired - Fee Related
- 1983-09-19 IT IT48990/83A patent/IT1197713B/it active
- 1983-09-28 MA MA20132A patent/MA19909A1/fr unknown
- 1983-09-30 AU AU19824/83A patent/AU563739B2/en not_active Ceased
- 1983-10-04 CH CH5395/83A patent/CH659251A5/fr not_active IP Right Cessation
- 1983-10-04 GB GB08326527A patent/GB2127827B/en not_active Expired
- 1983-10-04 CA CA000438264A patent/CA1203234A/fr not_active Expired
- 1983-10-04 FI FI833602A patent/FI77668C/fi not_active IP Right Cessation
- 1983-10-04 DK DK456483A patent/DK164062C/da not_active IP Right Cessation
- 1983-10-04 BE BE0/211641A patent/BE897906A/fr not_active IP Right Cessation
- 1983-10-04 IE IE2337/83A patent/IE56022B1/en not_active IP Right Cessation
- 1983-10-04 HU HU833444A patent/HU190506B/hu not_active IP Right Cessation
- 1983-10-04 ES ES526212A patent/ES526212A0/es active Granted
- 1983-10-05 NL NL8303409A patent/NL8303409A/nl not_active Application Discontinuation
- 1983-10-05 JP JP58185211A patent/JPS59116300A/ja active Granted
- 1983-10-05 OA OA58129A patent/OA07558A/xx unknown
- 1983-10-05 DE DE19833336292 patent/DE3336292A1/de active Granted
- 1983-10-05 AT AT0352783A patent/AT385996B/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA71183A (de) | Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate | |
| AT373599B (de) | Verfahren zur herstellung neuer rifamycinderivate | |
| AT389302B (de) | Verfahren zur herstellung neuer 3-benzylidencamphersulfonamidderivate | |
| PT77797A (de) | Verfahren zur herstellung neuer 1-azolyl-2-aryl-3-fluoralkan-2--ol-derivate | |
| ATA376184A (de) | Verfahren zur herstellung neuer polysubstituierter naphthalinderivate | |
| AT368755B (de) | Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate | |
| AT385996B (de) | Verfahren zur herstellung neuer dichlorierter derivate aus der reihe der 16alpha -methylpregnane | |
| AT381104B (de) | Verfahren zur herstellung neuer cyclopeptidderivate | |
| ATA444982A (de) | Verfahren zur herstellung neuer bisindolalkaloidderivate | |
| ATA34983A (de) | Verfahren zur herstellung neuer benzothiophenderivate | |
| ATA110680A (de) | Verfahren zur herstellung neuer o-trimethyl- silyl-cellulosen | |
| AT376217B (de) | Verfahren zur herstellung neuer 3-chlorchinolinderivate | |
| ATA222981A (de) | Verfahren zur herstellung neuer alkoxyalkanoylcarnitinhydrohalogeniden | |
| ATA135183A (de) | Verfahren zur herstellung neuer benzimidazolderivate | |
| AT387228B (de) | Verfahren zur herstellung neuer rhodanphenylazofarbstoffe | |
| AT386210B (de) | Verfahren zur herstellung neuer 4-carbamoyloxyoxa-zaphosphorine | |
| ATA540581A (de) | Verfahren zur herstellung neuer thiocarnitine | |
| AT375071B (de) | Verfahren zur herstellung von phenylpyridazinverbindungen | |
| ATA294283A (de) | Verfahren zur herstellung neuer tetrazinderivate | |
| AT371710B (de) | Verfahren zur herstellung galenischer zubereitungen | |
| ATA373985A (de) | Verfahren zur herstellung neuer carbapenemderivate | |
| ATA374085A (de) | Verfahren zur herstellung neuer carbapenemderivate | |
| AT380885B (de) | Verfahren zur herstellung neuer organophosphonothioderivate | |
| ATA8785A (de) | Verfahren zur herstellung neuer benzimidazolderivate | |
| AT381932B (de) | Verfahren zur herstellung neuer 1-sulfo-2-oxoazetidin-derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee | ||
| ELJ | Ceased due to non-payment of the annual fee |